Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030
© 2023. Springer-Verlag Italia S.r.l., part of Springer Nature..
The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in particular aims to ensure healthy lives and promote well-being for all at all ages and includes several targets to enhance health. This review presents a "headache-tailored" perspective on how to achieve SDG 3 by focusing on six specific actions: targeting chronic headaches; reducing the overuse of acute pain-relieving medications; promoting the education of healthcare professionals; granting access to medication in low- and middle-income countries (LMIC); implementing training and educational opportunities for healthcare professionals in low and middle income countries; building a global alliance against headache disorders. Addressing the burden of headache disorders directly impacts on populations' health, as well as on the possibility to improve the productivity of people aged below 50, women in particular. Our analysis pointed out several elements, and included: moving forward from frequency-based parameters to define headache severity; recognizing and managing comorbid diseases and risk factors; implementing a disease management multi-modal management model that incorporates pharmacological and non-pharmacological treatments; early recognizing and managing the overuse of acute pain-relieving medications; promoting undergraduate, postgraduate, and continuing medical education of healthcare professionals with specific training on headache; and promoting a culture that favors the recognition of headaches as diseases with a neurobiological basis, where this is not yet recognized. Making headache care more sustainable is an achievable objective, which will require multi-stakeholder collaborations across all sectors of society, both health-related and not health-related. Robust investments will be needed; however, considering the high prevalence of headache disorders and the associated disability, these investments will surely improve multiple health outcomes and lift development and well-being globally.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
|---|---|
| Enthalten in: |
The journal of headache and pain - 24(2023), 1 vom: 27. Okt., Seite 140 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Martelletti, Paolo [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Global burden of disease study |
|---|
| Anmerkungen: |
Date Completed 30.10.2023 Date Revised 10.02.2024 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1186/s10194-023-01666-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363769552 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363769552 | ||
| 003 | DE-627 | ||
| 005 | 20240210232812.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1186/s10194-023-01666-2 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1286.xml |
| 035 | |a (DE-627)NLM363769552 | ||
| 035 | |a (NLM)37884869 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Martelletti, Paolo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.10.2023 | ||
| 500 | |a Date Revised 10.02.2024 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. Springer-Verlag Italia S.r.l., part of Springer Nature. | ||
| 520 | |a The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in particular aims to ensure healthy lives and promote well-being for all at all ages and includes several targets to enhance health. This review presents a "headache-tailored" perspective on how to achieve SDG 3 by focusing on six specific actions: targeting chronic headaches; reducing the overuse of acute pain-relieving medications; promoting the education of healthcare professionals; granting access to medication in low- and middle-income countries (LMIC); implementing training and educational opportunities for healthcare professionals in low and middle income countries; building a global alliance against headache disorders. Addressing the burden of headache disorders directly impacts on populations' health, as well as on the possibility to improve the productivity of people aged below 50, women in particular. Our analysis pointed out several elements, and included: moving forward from frequency-based parameters to define headache severity; recognizing and managing comorbid diseases and risk factors; implementing a disease management multi-modal management model that incorporates pharmacological and non-pharmacological treatments; early recognizing and managing the overuse of acute pain-relieving medications; promoting undergraduate, postgraduate, and continuing medical education of healthcare professionals with specific training on headache; and promoting a culture that favors the recognition of headaches as diseases with a neurobiological basis, where this is not yet recognized. Making headache care more sustainable is an achievable objective, which will require multi-stakeholder collaborations across all sectors of society, both health-related and not health-related. Robust investments will be needed; however, considering the high prevalence of headache disorders and the associated disability, these investments will surely improve multiple health outcomes and lift development and well-being globally | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Global burden of disease study | |
| 650 | 4 | |a Low- and middle-income countries | |
| 650 | 4 | |a Medication overuse headache | |
| 650 | 4 | |a Migraine | |
| 650 | 4 | |a Sustainable development goals | |
| 650 | 4 | |a Tension-type headache | |
| 700 | 1 | |a Leonardi, Matilde |e verfasserin |4 aut | |
| 700 | 1 | |a Ashina, Messoud |e verfasserin |4 aut | |
| 700 | 1 | |a Burstein, Rami |e verfasserin |4 aut | |
| 700 | 1 | |a Cho, Soo-Jin |e verfasserin |4 aut | |
| 700 | 1 | |a Charway-Felli, Augustina |e verfasserin |4 aut | |
| 700 | 1 | |a Dodick, David W |e verfasserin |4 aut | |
| 700 | 1 | |a Gil-Gouveia, Raquel |e verfasserin |4 aut | |
| 700 | 1 | |a Grazzi, Licia |e verfasserin |4 aut | |
| 700 | 1 | |a Lampl, Christian |e verfasserin |4 aut | |
| 700 | 1 | |a MaassenVanDenBrink, Antoinette |e verfasserin |4 aut | |
| 700 | 1 | |a Minen, Mia T |e verfasserin |4 aut | |
| 700 | 1 | |a Mitsikostas, Dimos Dimitrios |e verfasserin |4 aut | |
| 700 | 1 | |a Olesen, Jes |e verfasserin |4 aut | |
| 700 | 1 | |a Owolabi, Mayowa Ojo |e verfasserin |4 aut | |
| 700 | 1 | |a Reuter, Uwe |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz de la Torre, Elena |e verfasserin |4 aut | |
| 700 | 1 | |a Sacco, Simona |e verfasserin |4 aut | |
| 700 | 1 | |a Schwedt, Todd J |e verfasserin |4 aut | |
| 700 | 1 | |a Serafini, Gianluca |e verfasserin |4 aut | |
| 700 | 1 | |a Surya, Nirmal |e verfasserin |4 aut | |
| 700 | 1 | |a Tassorelli, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Shuu-Jiun |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yonggang |e verfasserin |4 aut | |
| 700 | 1 | |a Wijeratne, Tissa |e verfasserin |4 aut | |
| 700 | 1 | |a Raggi, Alberto |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The journal of headache and pain |d 2000 |g 24(2023), 1 vom: 27. Okt., Seite 140 |w (DE-627)NLM159569303 |x 1129-2377 |7 nnns |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:1 |g day:27 |g month:10 |g pages:140 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1186/s10194-023-01666-2 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 24 |j 2023 |e 1 |b 27 |c 10 |h 140 | ||